Cancer drugs? The real story is more tragic



[ad_1]

The headlines on cancer always arouse the interest of the public. Many of us are confronted with this disease in different forms in a close environment, so even the humble news about a potential healing is often very emotional. When the title says "scientists have discovered a cancer drug", it's already a real bomb.

The news of a drug soon available, which more or less effectively fights cancer, appears periodically, giving people false hopes of joy.

What happened?

The Israeli daily Jerusalem Post has published an interview with representatives of a small local company, Accelerated Evolution Biotechnologies, who presented their new product. Since 2000, they have been creating a "medicine that can cure cancer" and announce a potential advance in this area.

The title of the article is rather cautious: "A cancer drug? Israeli scientists believe to have found it.

Dan Aridor, a spokesman for the company cited in the article, told us about the treatment they take, and said, "We think we will be able to offer a complete cure. of cancer in the years to come. "

World News on Cancer Drugs (Photo Producer)

World News on Cancer Drugs (Photo Producer)

However, even this statement is bold, because until now, the team of scientists has done only a preliminary study on mice. In addition, they have not yet published the results of their research in Wired labeled mice. According to this portal, the behavior of such a business can be based on the desire to attract more investment.

The article does not provide either the opinion of expert oncologists. There was no question of a "barrier to human trials", which is not surpbaded by the vast majority of authors of such research.

"Anyone who understands something about oncology will tell you that many extremely promising studies have not yet pbaded the stage of human testing." Recently, it has been estimated that only 3.4% of all anticancer drugs that we produce reach the sales market, "writes Wired.

Experts are outraged by irresponsible statements

According to experts, the company could put up to 6 to 7 years to test the results of studies on mice before studies on humans. And if they succeed in getting approval from the US drug control services for "accelerated drug development".

"I mean, I would like to see an anti-cancer drug already developed, but I do not believe it because there is no human research yet," said Funtleyder, an badyst with 20 years of experience in the pharmaceutical market.

Similarly, American oncologist Ben Neel, who spoke with Fox News, also thought. "It's more likely to be just another statement in a long line of misleading, irresponsible and cruel promises to cancer patients," said the doctor.

The problem of dissemination of misinformation

The adapted translation has been provided not only by the British Daily Star, but even publications such as the New York Post or Forbes have written about the "feats" of Israeli scholars.

Later, Forbes, as he corrected his own mistakes, published two other texts in which scientists spoke criticized the early statements of scientists. The editor of the Department of Public Health even called his comment: "Israeli society claims to have developed anti-cancer drugs, do not believe them.

Cancer drugs? Why not believe the information broadcast (photo producer)

Cancer drugs? Why not believe the information broadcast (photo producer)

Wired points out that this behavior of information portals is not strange in the extremely fast online media. The problem is that "false news" spreads much faster and includes more people than the "denials" that follow.

Therefore, the title "Cancer healed!" Will go further and faster than the explanations of "boring scientists" that such statements are lacking.

Wired also provided a basic math for this. When Forbes published his first information on "cancer drugs" for Jewish scientists on his Twitter account, he collected 47 comments, 821 distributions and 1635 hits. The next day, the article on the "180-degree rotation" continued with expert feedback, garnering 4 comments, 30 shared and 61 favorites.

[ad_2]
Source link